Wells Fargo’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
FDCDDQ
DI
DWS
DSC
Wells Fargo's BBC Position: Q4 2023 in Review
Wells Fargo sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2023, closing a stake of 322 shares — an estimated $6.32K sold.
Wells Fargo first reported a position in BBC in Q4 2016 and held it in 23 quarters. The position peaked at $53K in Q4 2020. 18 funds tracked by Wall St. Rank hold BBC as of Q4 2023.
- Wells Fargo reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 322 Virtus Biotech Clinical Trials ETF shares in Q4 2023, an estimated $6.32K.
- Wells Fargo first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2016 and held it in 23 quarters.
- Wells Fargo's Virtus Biotech Clinical Trials ETF position peaked at $53K in Q4 2020.
- 18 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.